IL-27/IL-27RA signaling may modulate inflammation and progression of benign prostatic hyperplasia via suppressing the LPS/TLR4 pathway

Hua-Cheng Lo(National Taiwan University), Eric Y. Chuang(National Taiwan University)
Translational Cancer Research
August 1, 2020
Cited by 6


Related Papers